Neogen (NEOG) Aktie Kurs

Neogen Kurs

NASDAQ·LUKKET
11,93
​
Markedet lukket

De seneste 19 år voksede Neogens omsætning med 12,9 % årligt og nåede 870,40 Mio. USD. Indtjening pr. aktie er vokset med 5,2 % om året de seneste 15 år. For Neogen er nettoavance på -0,9 % ned i forhold til 9,2 % for et par år siden. Konsensus 12-måneders kursmål for Neogen er 13,00 USD, cirka over kursen med 9,0 %. Af 11 analytikere anbefaler 8 køb — den samlede vurdering er Køb.

Neogen aktiekurs

Hent disse data via Eulerpool API

Neogen aktie og aktieanalyse

Neogen Corp er en førende leverandør af løsninger inden for fødevaresikkerhed og dyresundhed med hovedkvarter i Lansing, Michigan, USA. Selskabet blev grundlagt i 1982 af James Herbert og havde oprindeligt fokus på udvikling og produktion af hurtige tests til mejerisektoren. Siden da er Neogen blevet en internationalt opererende virksomhed med over 25 datterselskaber og 1.800 ansatte. Neogens forretningsmodel er baseret på at levere løsninger til sikre og sunde fødevareforsyninger og husdyrhold. Virksomheden opererer inden for to hoveddivisioner: Food Safety og Animal Safety. Inden for disse divisioner tilbyder Neogen et bredt udvalg af testkits, diagnostiske værktøjer, informationsstyringssoftware og andre produkter, der hjælper med at minimere risikoen for madforgiftning og forbedre husdyrenes sundhed. Inne i Food Safety-divisionen tilbyder Neogen en række forskellige testkits, der gør det muligt for fødevareproducenter og detailhandlere hurtigt og nemt at opdage forskellige typer kontaminanter i fødevarer. Dette inkluderer tests for salmonella, E. coli, listeria og mykotoksiner. Virksomheden leverer også værktøjer til overvågning af vandkvalitet og verifikation af rengørings- og desinfektionsprocesser i fødevareforarbejdningsanlæg. Inne i Animal Safety-divisionen tilbyder Neogen ligeledes et omfattende udvalg af diagnostiske værktøjer til at forbedre husdyrenes sundhed. Testene omfatter smitsomme sygdomme som brucellose, BSE (kvægtsygdommen), mastitis og leukæmi. Derudover leverer Neogen værktøjer til identifikation af dyr og styring af data vedrørende dyresundhed. Neogen har desuden specialiseret sig i udviklingen af teknologier til at forbedre dyresundhed og ernæring, såsom probiotika og kosttilskud til husdyr. Et andet fokusområde for Neogen er udviklingen af informationsstyringssoftware, der gør det muligt for fødevareproducenter og detailhandlere at effektivisere processerne inden for fødevaresikkerhed og kvalitet. Softwaren giver virksomheder mulighed for at spore tests, analysere data og implementere bedste praksis for at minimere risikoen for madforgiftning. I de seneste år har Neogen også øget sin fokus på det globale marked, især det asiatiske marked. Virksomheden har datterselskaber i forskellige dele af verden, herunder Europa, Latinamerika og Asien. Neogen arbejder tæt sammen med lokale myndigheder for at tilbyde sine produkter i overensstemmelse med lokale krav. Konkluderende kan det siges, at Neogen Corp er en førende leverandør af løsninger inden for fødevaresikkerhed og dyresundhed med fokus på udvikling og produktion af testkits, diagnostiske værktøjer og informationsstyringssoftware. Virksomheden har oplevet imponerende vækst i de seneste årtier og opererer nu internationalt. Med sin engagement for sikre og sunde fødevareforsyninger og husdyrhold sætter Neogen standarder for branchen.

Hyppigt stillede spørgsmål om Neogen-aktien

Neogen Corp is a leading company in the field of food and animal safety. Their business model revolves around providing diagnostic solutions and expertise to various industries. They offer a wide range of products and services including food safety testing, animal health products, and genomic testing. Neogen Corp utilizes advanced technologies and innovations to ensure the quality and safety of the food supply chain, prevent diseases in animals, and improve overall agricultural productivity. With a strong focus on research and development, Neogen Corp continuously delivers reliable and sustainable solutions to meet the evolving needs of their customers worldwide.

Neogen Corp is primarily active in the food safety and animal health industries.

The main competitors of Neogen Corp in the market include companies such as IDEXX Laboratories, Zoetis Inc., and Thermo Fisher Scientific Inc.

Neogen Corp, founded in 1982, is a leading global company specializing in food and animal safety solutions. Headquartered in Lansing, Michigan, Neogen is committed to developing innovative products for the agricultural, food, and pharmaceutical industries. With a diverse range of products and services, Neogen offers reliable and accurate diagnostic test kits, hygiene monitoring systems, and animal genomics solutions. They have built a solid reputation for their commitment to quality, customer service, and staying at the forefront of technological advancements. Neogen Corp's continuous dedication to improving food safety and animal health has made them a trusted and respected name in the industry.

Neogen Corp has achieved several significant milestones throughout its history. The company successfully developed and introduced rapid food and animal safety tests, revolutionizing the industry. They expanded their product portfolio to include diagnostics for human healthcare, veterinary medicine, and agricultural concerns globally. Neogen Corp's continuous innovations in genomics, biosecurity, and animal safety further propelled its growth. The company established strategic partnerships and collaborations to enhance its product offerings and market reach. Neogen Corp's commitment to quality, accuracy, and reliability has earned them a strong reputation with customers worldwide. With a track record of achievements, Neogen Corp continues to lead as a trusted provider of innovative solutions in the field of food and animal safety.

Neogen Corp is primarily present in several countries and regions around the world. These include the United States, Canada, Mexico, and various countries in Europe, such as Belgium, France, Germany, and the United Kingdom. Additionally, Neogen Corp has a strong presence in Asia, with operations in China and southeast Asian countries like Singapore. With its global reach, Neogen Corp continues to expand its presence and offer its innovative products and services to customers in diverse markets.

Neogen Corp is a company that values innovation, integrity, and commitment to quality. Their corporate philosophy revolves around providing solutions for the food and animal safety industries through advanced technology and dedicated research. With a focus on developing and marketing products to ensure the safety of food, feed, and animal health, Neogen Corp aims to be a trusted partner for agricultural, veterinary, and food processing industries. By consistently delivering high-quality products and services, Neogen Corp reinforces its commitment to the safety and well-being of both humans and animals, making it a reputable player in the industry.

Analytikere sætter i øjeblikket et gennemsnitligt kursmål på 13,00 USD for Neogen-aktien (median: 13,00 USD), svarende til +9,0 % i forhold til seneste kurs. Konsensus bygger på 11 analytikervurderinger.

11 analytikere vurderer i øjeblikket Neogen-aktien: 8 anbefaler køb, 3 hold og 0 salg.

Omregnet til den aktuelle valutakurs handles Neogen-aktien til 10,65 EUR (11,93 USD).

Neogen-aktien (NEOG) er noteret på 2 børser, herunder: NASDAQ (NEOG), Frankfurt (NG2.F).

The company Neogen Corp is a leading provider of food and animal health products. Its business model is focused on developing high-quality products and services that help improve food and animal health. The company is divided into two main areas: food and animal health. In the food sector, Neogen offers testing systems and diagnostic products that are used to monitor food safety and quality. Neogen's testing systems are used in food technology, animal feed control, and animal health. The products range from allergen-specific tests to detection methods for contamination or spoilage in food. In the animal health segment, the company offers a wide range of therapeutic and preventive products to promote animal health and performance. The product range includes products for the diagnosis and treatment of animals as well as medications, feed additives, and other products. Neogen Corp also offers services such as laboratory services and training. Neogen focuses on innovation and regularly invests in research and product development. The company works closely with leading universities and institutes to develop innovative products that meet the needs of customers. Product development focuses on creating effective solutions for animal health, preventing food contamination, and improving food quality. The company operates internationally and offers its products and services worldwide. Neogen has subsidiaries in Europe, Asia, and South America and works with distributors in over 60 countries. Neogen's global presence enables the company to meet the diverse needs of its customers in different countries and regions. In addition to its business activities, Neogen emphasizes its commitment to sustainability and social responsibility. The company is dedicated to promoting environmental and food quality, as well as the safety and health of animals. It also works to develop and improve its products and services to promote these goals. Neogen Corp is a leading provider of food and animal health products. The company offers a wide range of products and services aimed at improving food and animal health standards. The company relies on innovation and investments in research and development to create high-quality solutions for customers around the world. With a strong global presence and a commitment to sustainability and social responsibility, Neogen is well positioned to drive growth in these critical areas of the economy.

-omsætningen for Neogen er 870,40 Mio. USD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

-overskuddet for Neogen er -7,90 Mio. USD. Nettooverskuddet afspejler virksomhedens rentabilitet efter fradrag af alle udgifter.

Pris-til-indtjening-forholdet (P/E) for Neogen er i øjeblikket -329,22. P/E-forholdet sammenligner den nuværende aktiekurs med indtjeningen pr. aktie og hjælper investorer med at vurdere værdiansættelsen af Neogen-aktien.

Pris-til-salgs-forholdet (P/S) for Neogen er i øjeblikket 2,99. P/S-forholdet sammenligner markedskapitalisering med årlig omsætning og fungerer som en værdiansættelsesmetrik for Neogen-aktien.

AlleAktien-kvalitetsscore for Neogen er 2/10.

ISIN for Neogen er US6404911066. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Neogen er 883297. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Neogen er NEOG. Tickersymbolet bruges til at handle Neogen-aktier på børsen.

Fair værdiTerminal
12,04 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Sundhedsvæsens Udstyr & Forsyninger
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
330.197,27 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside neogen.com
Land
Valuta
USD
Børsintroduktion
23. aug. 1989
ISIN
US6404911066
CUSIP
640491106
SEDOL
2630085
Markedsværdi
52-ugers interval
AAQS
2 / 10
PEG-forhold
-27,20
P/E-forhold
P/Ee 2027
39,10
P/Ee 2028
28,62
P/Ee 2029
22,93
P/Ee 2030
23,85
P/Ee 2031
22,08
P/S
P/Se
2,94
EV/EBIT
—
K/B-forhold
1,24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-0,27 %
Sidst opdateret 14. okt. 2026, 00.42

Neogen Ticker

FRANKFURT · NG2.FNASDAQ · NEOG

Neogen FIGI

NEOG:US · BBG000C1BCK2NEOG:UA · BBG000C1BCR5NEOG:UC · BBG000C1BD57NEOG:UN · BBG000C1BFF1NEOG:UP · BBG000C1BFR8NEOG:UB · BBG000C1BGV1NEOG:UM · BBG000C1BJN4NEOG:UX · BBG000C1BKL3NEOG:UD · BBG000C1BMJ2NEOG:UW · BBG000C1BPB3NEOG:UF · BBG000C1BPX9NEOG:VY · BBG000C1BQ94

Alle fundamentale data om Neogen i deep dive

Vores aktieanalyse af Neogen-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Neogen. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: